If you have traveled to any area in the US that is considered a “hot spot” with increasing amount of cases of COVID please alert our office before coming in for any appointment. All VCS sites will be conducting temperature checks for all patients and visitors at entrances. For your safety, you will be asked to use a mask, if you do not have one, a mask will be provided. If a person presents with a temperature, you will be asked to return home and further instructions will be given by your health care team. For our patients protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. FOR THE LATEST UP TO DATE INFORMATION, ALERTS AND CANCELLATIONS PLEASE CLICK HERE

Amy J. Irwin, MD

VCS Physicians

Amy J. Irwin, MD Headshot

Now more than ever, there is reason to be hopeful as we treat our patients’ cancer. Our ability to use, in novel ways "old medicines" and the ever-expanding frontier of new cancer treatments - equip Virginia Cancer Specialists with the tools we need to fight for and alongside our patients.

Work and Credentials:

Primary Location

Loudoun Office

Position

Medical Oncologist

Board Certification

Medical Oncology

Fellowship

Georgetown University Hospital, Medical Oncology and Hematology

Residency

University of Pennsylvania

Medical School

Georgetown University School of Medicine

College

Haverford College

Dr. Irwin’s commitment to caring for and treating oncology and hematology patients led her to join the Loudoun Office of Virginia Cancer Specialists in 2008. She is a member of the American Society of Clinical Oncology and is a national clinical trials researcher. Dr. Irwin regularly lectures in the community for Life With Cancer, has educated the public on clinical trials for the Leukemia and Lymphoma Society, and has given multiple physician Grand Rounds at INOVA Loudoun Hospital to educate her peers on current oncology and hematology cases and developments.

A recognized expert in the fight against breast cancer, Dr. Irwin is part of the national U.S. Oncology Breast Cancer Research Committee, has been interviewed as a breast cancer specialist on television and in magazines, and is repeatedly called on to speak at charity events for breast cancer awareness and prevention.

Awarded multiple commendations for outstanding patient care, Dr. Irwin has a long-standing commitment to providing the best outcomes for her patients. She completed her Internal Medicine residency at the Hospital of the University of Pennsylvania in 2005, where she was awarded the University of Pennsylvania’s Holmes Award in Patient Oriented Evaluative Research. Dr. Irwin went on to complete her Hematology/Oncology fellowship after returning to Georgetown University Hospital’s Lombardi Cancer Center. Her research and clinical focus during fellowship was in breast cancer and she completed a Bone Marrow Transplant rotation at the National Cancer Institute in Bethesda, Maryland.

 



Practice Blog

September 6, 2017

Amy J. Irwin, MD

Read More
May 7, 2020

Scalp Cooling and Cancer Care during COVID19 May 13th 2020 @ 4pm EST - Live Zoom Webinar

Read More
May 22, 2018

Virginia Cancer Specialists Collaborating with Caris Life Sciences to Present New Molecular Findings at the 2018 ASCO Annual Meeting

Read More

Physician Publications

May 7, 2020

Scalp Cooling and Cancer Care during COVID19 May 13th 2020 @ 4pm EST - Live Zoom Webinar

Read More
October 14, 2019

Phase II Study of Eribulin Mesylate Administered Biweekly in Patients With Human Epidermal Growth Factor Receptor-2–negative Metastatic Breast Cancer

Read More
May 22, 2018

Virginia Cancer Specialists Collaborating with Caris Life Sciences to Present New Molecular Findings at the 2018 ASCO Annual Meeting

Read More

More Publications by Amy J. Irwin, MD

March 15, 2018

New clinical data for chemotherapy drug administered in metastatic breast cancer co-presented by Dr. Amy Irwin of Virginia Cancer Specialists

Read More

Clinical Trials (1)

Clinical Trial 19049

The main purpose of this study is to learn if the usual chemotherapy given before surgery (neoadjuvant therapy) for breast cancer plus the experimental drug, atezolizumab, is better than the usual chemotherapy plus a placebo. (A placebo is a drug that looks like the study drug but contains no medication.) The usual chemotherapy in this study is paclitaxel (WP) and carboplatin followed by doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC). Usually, after neoadjuvant therapy and surgery for triple negative breast cancer, no additional treatment is given unless the cancer returns. This study will also look at continuing treatment after surgery with atezolizumab or the placebo. To be better, atezolizumab given with the neoadjuvant therapy should be better at: 1) decreasing the amount of tumor in the breast than the placebo given with the usual chemotherapy and 2) decreasing the chance of the cancer from returning after surgery. Another purpose of this study is to test the good and bad effects of atezolizumab when added to the usual chemotherapy. Atezolizumab may keep your cancer from growing but it can also cause side effects.

Primary Location

Loudoun Office Office

Loudoun Office

Learn More

Other Locations

Awards

January 1, 2020

2020 Virginia Living Top Doctors


January 1, 2019

Northern Virginia Magazine Top Doctor 2019


January 1, 2018

2018 Washingtonian Magazine Top Doctor Nomination


January 1, 2018
Virginia Living Magazine Top Doctors 2018

Top Doctors Virginia Living Magazine 2018


January 1, 2018
Northern Virginia Magazine Top Doctors 2018

Northern Virginia Magazine Top Doctors 2018


September 9, 2016
Washingtonian Magazine

Washingtonian Top Doctor 2016


March 31, 2013
Washington Post Magazine

Rising Star 2013